This inventor holds 2 USPTO granted patents. Top assignees: Pfizer Corporation, Pfizer Products Inc.. Active years: 2001-2005.
Company Filing History:
2 out of 4,486 
1 out of 47 
Years Active: 2001-2005
Title: R Scott Obach: Innovator in Pharmaceutical Compounds
Introduction
R Scott Obach is a notable inventor based in Gales Ferry, CT (US). He has made significant contributions to the field of pharmaceuticals, holding 2 patents that focus on innovative compounds aimed at treating various medical conditions.
Latest Patents
One of his latest patents is for aryl fused azapolycyclic compounds. This invention is directed to compounds of the formula (I) and their pharmaceutically acceptable salts, wherein R, R, and R are as defined herein. It also includes intermediates for the synthesis of such compounds, pharmaceutical compositions containing these compounds, and methods of using them in the treatment of nicotine addiction/withdrawal and CNS disorders. Another significant patent is for 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives. This invention relates to novel derivatives of the formula that have potential therapeutic applications.
Career Highlights
Throughout his career, R Scott Obach has worked with prominent companies such as Pfizer Corporation and Pfizer Products Inc. His work in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical research.
Collaborations
He has collaborated with notable colleagues, including Anne E Hagen and Douglas Alan Scully, which has further enriched his research and development efforts.
Conclusion
R Scott Obach's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of complex compounds and their potential applications in treating significant health issues.